ArticleFrontiers in oncology2022
GCLDNet: Gastric cancer lesion detection network combining level feature aggregation and attention feature fusion.
Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 10 citations in OpenAlex.
- Transformer-Based Feature Extraction and Optimized Deep Neural Network for Gastric Cancer Detection.Journal of imaging informatics in medicine · 2026Article
- Interpretable deep learning for gastric cancer detection: a fusion of AI architectures and explainability analysis.Frontiers in immunology · 2025Article
- FC-YOLO: a fast inference backbone and lightweight attention mechanism-enhanced YOLO for detecting gastric adenocarcinoma in pathological image.Frontiers in oncology · 2025Article
- RAD-UNet: Research on an improved lung nodule semantic segmentation algorithm based on deep learning.Frontiers in oncology · 2023Article
- FibroVit-Vision transformer-based framework for detection and classification of pulmonary fibrosis from chest CT images.Frontiers in medicine · 2023Article
- Automated Classification of Idiopathic Pulmonary Fibrosis in Pathological Images Using Convolutional Neural Network and Generative Adversarial Networks.Diagnostics (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Analysis of histopathological slices of gastric cancer is the gold standard for diagnosing gastric cancer, while manual identification is time-consuming and highly relies on the experience of pathologists. Artificial intelligence methods, particularly deep learning, can assist pathologists in finding cancerous tissues and realizing automated detection. However, due to the variety of shapes and sizes of gastric cancer lesions, as well as many interfering factors, GCHIs have a high level of complexity and difficulty in accurately finding the lesion region. Traditional deep learning methods cannot effectively extract discriminative features because of their simple decoding method so they cannot detect lesions accurately, and there is less research dedicated to detecting gastric cancer lesions. Methods: We propose a gastric cancer lesion detection network (GCLDNet). At first, GCLDNet designs a level feature aggregation structure in decoder, which can effectively fuse deep and shallow features of GCHIs. Second, an attention feature fusion module is introduced to accurately locate the lesion area, which merges attention features of different scales and obtains rich discriminative information focusing on lesion. Finally, focal Tversky loss (FTL) is employed as a loss function to depress false-negative predictions and mine difficult samples. Results: Experimental results on two GCHI datasets of SEED and BOT show that DSCs of the GCLDNet are 0.8265 and 0.8991, ACCs are 0.8827 and 0.8949, JIs are 0.7092 and 0.8182, and PREs are 0.7820 and 0.8763, respectively. Conclusions: Experimental results demonstrate the effectiveness of GCLDNet in the detection of gastric cancer lesions. Compared with other state-of-the-art (SOTA) detection methods, the GCLDNet obtains a more satisfactory performance. This research can provide good auxiliary support for pathologists in clinical diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.